Details for Patent: 11,229,378
✉ Email this page to a colleague
Which drugs does patent 11,229,378 protect, and when does it expire?
Patent 11,229,378 protects ABILIFY MYCITE KIT and is included in one NDA.
This patent has one hundred and twenty-five patent family members in twenty-two countries.
Summary for Patent: 11,229,378
| Title: | Communication system with enhanced partial power source and method of manufacturing same |
| Abstract: | The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can also measure the conditions of the environment surrounding the system. |
| Inventor(s): | Frank; Jeremy (San Francisco, CA), Bjeletich; Peter (Livermore, CA), Hafezi; Hooman (Redwood City, CA), Azevedo; Robert (Albany, CA), Duck; Robert (San Francisco, CA), Pesic; Iliya (Saratoga, CA), Costello; Benedict (Piedmont, CA), Snyder; Eric (South San Francisco, CA) |
| Assignee: | OTSUKA PHARMACEUTICAL CO., LTD. (Tokyo, JP) |
| Application Number: | 16/689,578 |
|
Patent Claim Types: see list of patent claims | Use; Process; Device; |
Drugs Protected by US Patent 11,229,378
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-001 | Nov 13, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-002 | Nov 13, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-003 | Nov 13, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-004 | Nov 13, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-005 | Nov 13, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,229,378
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006239221 | ⤷ Try a Trial | |||
| Australia | 2012282690 | ⤷ Try a Trial | |||
| Australia | 2012282772 | ⤷ Try a Trial | |||
| Australia | 2012282776 | ⤷ Try a Trial | |||
| Australia | 2012282777 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
